CAS: 329907-28-0 - TTP 22
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
TTP 22 REF: IN-DA00C6I3CAS: 329907-28-0 | 98% | 153.00 €~526.00 € | Tue 17 Dec 24 | |
TTP 22 REF: TM-T1828CAS: 329907-28-0 | 97.08% - 97.78% | 38.00 €~477.00 € | Fri 27 Dec 24 | |
TTP 22 REF: 3D-ENA90728CAS: 329907-28-0 | Min. 95% | To inquire | Tue 28 Jan 25 |
Ref: IN-DA00C6I3
10mg | 153.00 € | ||
50mg | 168.00 € | ||
100mg | 282.00 € | ||
250mg | 526.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
TTP 22
CAS:329907-28-0
TTP 22: ATP-competitive CK2 inhibitor; IC50/Ki: 0.1 μM/40 nM; >250x selective over JNK3, ROCK1, MET.
Formula:
C16H14N2O2S2
Purity:
97.08% - 97.78%
Color and Shape:
Solid
Molecular weight:
330.42
Ref: TM-T1828
1mg | 38.00 € | ||
5mg | 80.00 € | ||
10mg | 108.00 € | ||
25mg | 218.00 € | ||
50mg | 323.00 € | ||
100mg | 477.00 € | ||
1mL*10mM (DMSO) | 98.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
TTP 22
CAS:329907-28-0
TTP 22 is a tumor-targeted protein that has been shown to be effective in the …
Formula:
C16H14N2O2S2
Purity:
Min. 95%
Molecular weight:
330.42 g/mol
Ref: 3D-ENA90728
10mg | 249.00 € | ||
100mg | 991.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025